
MOLECULAR PARTNERS AG
Acción · CH0256379097 · A12DEH (XSWX)
3,05 CHF
13.06.2025 09:40
Cotizaciones actuales de MOLECULAR PARTNERS AG
Bolsa | Ticker | Moneda | Última operación | Precio | Variación diaria |
---|---|---|---|---|---|
![]() London |
0QXX.L
|
CHF
|
13.06.2025 09:40
|
3,05 CHF
| 3,10 CHF
-1,53 %
|
Rendimiento
Día | Semana | Mes | 3 meses | 6 meses | 1 año | 5 años |
---|---|---|---|---|---|---|
-1,53 % | 2,26 % | -12,03 % | -16,83 % | -38,27 % | -54,17 % | -54,17 % |
Perfil de la empresa para MOLECULAR PARTNERS AG Acción
Molecular Partners AG operates as a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic proteins. Its products candidates include Abicipar, a DARPin therapeutic candidate, which is in Phase III clinical trials for the treatment of neovascular wet age-related macular degeneration, as well as for diabetic macular edema; and MP0420, a multi-specific DARPin therapeutic candidate for the SARS-CoV-2 virus. The company develops MP0310, which is in Phase Ia clinical trials for immuno-oncology; MP0317, a tumor-localized immune agonist that activates immune cells in the tumor, which is in Phase I clinical trials; and MP0274 that is in Phase I clinical trials for HER2-positive cancers. It also develops MP0423 for treating COVID-19; MP0533, a CD3 T cell candidate for acute myeloid leukemia; and MP0250 for vascular endothelial growth factor, hepatocyte growth factor, and human serum albumin to increase half-life. Molecular Partners AG has agreements and collaboration with Novartis AG to develop, manufacture, and commercialize DARPin-conjugated radioligand therapies; Amgen SA; Allergan, Inc.; and discovery alliance with AbbVie Inc. in ophthalmology, as well as other third-party collaborators. The company was incorporated in 2004 and is headquartered in Schlieren, Switzerland.
Datos de la empresa
Nombre MOLECULAR PARTNERS AG
Empresa Molecular Partners AG
Sitio web
https://www.molecularpartners.com
Mercado principal
SIX
WKN A12DEH
ISIN CH0256379097
Tipo de valor Acción
Sector Healthcare
Industria Medical - Pharmaceuticals
CEO Dr. Patrick Amstutz Ph.D.
Capitalización de mercado 132 Mio
País Suiza
Moneda CHF
Empleados 0,2 T
Dirección Wagistrasse 14, 8952 Schlieren
Fecha de OPV 2014-11-05
Símbolos de cotización
Nombre | Símbolo |
---|---|
Frankfurt | 6ML.F |
London | 0QXX.L |
Otras acciones
Los inversores que tienen MOLECULAR PARTNERS AG también tienen las siguientes acciones en su cartera:
La plataforma financiera MoneyPeak rastrea y analiza inversiones y carteras.
Desde depósitos de valores hasta compras de criptomonedas.
Útil, simple y gratuito. Acciones, ETF, ETC, ETN, índices, fondos, bonos, certificados, divisas, opciones, derechos de suscripción.
Útil, simple y gratuito. Acciones, ETF, ETC, ETN, índices, fondos, bonos, certificados, divisas, opciones, derechos de suscripción.